
Salbutamol (Salbulin Novolizer) - Chronic Obstructive Pulmonary Disease (COPD)
You are here : Home > Formulary Search > Salbutamol (Salbulin Novolizer) - Chronic Obstructive Pulmonary Disease (COPD)
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Non Formulary
Formulations :
- Inhaler (dry powder)
Formulary Status :
Associated Icons :
Restrictions / Comments :
Documentation
Guidelines (Local)
PAD Profile
ChemicalSubstance :
Salbutamol (Salbulin Novolizer)
Indication :
Chronic Obstructive Pulmonary Disease (COPD)
Group Name :
SABA
Keywords :
Salbutamol inhalers, SABAs, bronchodilators, adrenoreceptor agonists, short acting beta 2 agonist, respiratory
Brand Names Include :
Salbulin Novolizer
Important Information :
Easyhaler Salbutamol is preferred. Ventolin Accuhaler is a suitable low-carbon alternative DPI.
Not for initiation in new patients.
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
2
Other Indications
Below are listed other indications that Salbutamol (Salbulin Novolizer) is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Chronic Obstructive Pulmonary Disease (COPD).
- Aclidinium bromide (Eklira Genuair)
- Aclidinium with formoterol (Duaklir Genuair)
- Beclometasone with formoterol (Fostair NEXThaler 100/6)
- Beclometasone with formoterol (Fostair)
- Beclometasone with formoterol (Proxor 100/6)
- Beclometasone with formoterol and glycopyrronium (Trimbow 87/5/9)
- Beclometasone with formoterol and glycopyrronium (Trimbow NEXThaler)
- Budesonide nebules
- Budesonide with formoterol (DuoResp Spiromax)
- Budesonide with formoterol (Fobumix Easyhaler)
- Budesonide with formoterol (Symbicort 200/6)
- Budesonide with formoterol (Symbicort Turbohaler 400/12)
- Dupilumab
- Fluticasone with salmeterol (Fusacomb Easyhaler)
- Fluticasone with salmeterol (Seretide Accuhaler)
- Fluticasone with umeclidinium and vilanterol (Trelegy Ellipta)
- Fluticasone with vilanterol (Relvar Ellipta)
- Formoterol (Easyhaler Formoterol)
- Formoterol (Oxis Turbohaler)
- Glycopyrronium (Seebri Breezhaler)
- Glycopyrronium with formoterol (Bevespi Aerosphere)
- Glycopyrronium with indacaterol (Ultibro Breezhaler)
- Indacaterol (Onbrez Breezhaler)
- Ipratropium (Atrovent)
- Ipratropium (nebules)
- Ipratropium with salbutamol (nebules)
- Olodaterol (Striverdi Respimat)
- Roflumilast
- Salbutamol (Easyhaler Salbutamol)
- Salbutamol (nebules)
- Salbutamol (Salamol Easi-Breathe)
- Salbutamol (Salamol)
- Salbutamol (Ventolin Accuhaler)
- Salbutamol (Ventolin Evohaler)
- Salmeterol (Serevent Evohaler / Serevent Accuhaler)
- Terbutaline (Bricanyl Turbohaler)
- Terbutaline (nebules / injection)
- Tiotropium (Braltus Zonda)
- Tiotropium (Spiriva HandiHaler)
- Tiotropium bromide (Spiriva Respimat)
- Tiotropium with olodaterol (Spiolto Respimat)
- Umeclidinium (Incruse Ellipta)
- Umeclidinium with vilanterol (Anoro Ellipta)
Committee Recommendations (1)
The locally preferred salbutamol devices are as follows:
Low carbon:
- Salbutamol Easyhaler (dry powder inhaler)
- Ventolin Accuhaler (dry powder inhaler)
Alternative devices:
- Salamol (MDI) is the locally preferred salbutamol metered dose inhaler device and should be used with a spacer device. It has a lower carbon footprint than the large volume MDIs such as Ventolin.
- Ventolin Evohaler (MDI)
Branded prescribing of inhaler devices is recommended.
See local COPD guidelines for more information